Showing results (31-40 of 231,054) with videos related to
Sort By:
Pageof 23,106
The Pediatric Infectious Disease Journal|December 23, 1999
Postmarketing evaluation of the safety and effectiveness of varicella vaccineS Black, H Shinefield, P Ray, et al.JAMA|February 2, 1994
Cost-effectiveness of a routine varicella vaccination program for US childrenT A Lieu, S L Cochi, S B Black, et al.Journal of Health Care for the Poor and Underserved|September 6, 2003
Comparing the medical expenses of adults with Medicaid and commercial insurance in a health maintenance organizationG Thomas Ray, Tracy A LieuThe Journal of Infectious Diseases|June 1, 1992
Safety, immunogenicity, and efficacy in infancy of oligosaccharide conjugate Haemophilus influenzae type b vaccine in a United States population: possible implications for optimal useS B Black, H R Shinefield, B Fireman, et al.JAMA|August 20, 1997
Risk of chronic arthropathy among women after rubella vaccination. Vaccine Safety Datalink TeamP Ray, S Black, H Shinefield, et al.Pediatrics|November 14, 1997
MMR2 immunization at 4 to 5 years and 10 to 12 years of age: a comparison of adverse clinical events after immunization in the Vaccine Safety Datalink project. The Vaccine Safety Datalink TeamR L Davis, E Marcuse, S Black, et al.The Pediatric Infectious Disease Journal|February 12, 2004
Safety of cold-adapted live attenuated influenza vaccine in a large cohort of children and adolescentsRandy Bergen, Steve Black, Henry Shinefield, et al.Pediatrics|June 11, 2014
Impact of vaccination on the epidemiology of varicella: 1995-2009Roger Baxter, Trung N Tran, Paula Ray, et al.Pediatrics|April 3, 2013
Long-term effectiveness of varicella vaccine: a 14-Year, prospective cohort studyRoger Baxter, Paula Ray, Trung N Tran, et al.Vaccine|July 19, 2011
Risk of rheumatoid arthritis following vaccination with tetanus, influenza and hepatitis B vaccines among persons 15-59 years of agePaula Ray, Steven Black, Henry Shinefield, et al.Pageof 23,106